As requested by some of y'all on this forum, here are the 2021 league tables, courtesy of Factset.
Global
Global League Tables - Sell-side Advisors
Global League Tables - Buy-side Advisors
United States
United States League Tables - Sell-side Advisors
United States League Tables - Buy-side Advisors
Global ECM
| +162 | Americas M&A League Table Q2 Updated | 70 | 1h |
| +132 | New Article: Dramatic Slide as UBS #22 (US) & New Leadership Desperately Needed | 25 | 1d |
| +72 | Restructuring: Anti-climactic Experience | 15 | 5h |
| +68 | A COMPLETE GUIDE TO SUMMER INTERNSHIP RECRUITING | 12 | 15h |
| +53 | IB Net Worth / Savings Check | 20 | 12h |
| +51 | Boutique firm wants access to my LinkedIn? | 40 | 15h |
| +36 | Investment Banking is Hard | 14 | 19h |
| +33 | Investment Banking in Mexico | 9 | 2d |
| +25 | PWP vs BofA | 21 | 9h |
| +21 | Excel macros for QOL formatting | 0 | 5d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Thanks for posting! Interesting to see Rothschild's disparity between their global and US presence. Basically tied with JEF globally but not even in the top 20 in the US. Always heard their global and domestic reputations differed but didn't realize how just how big the difference is.
A lot of Balance-sheet banks (JPM, RBC, BMO, Barclays, DB, UBS) are much higher on the league tables for buy-side advisory because they get provide the financing for the transactions and also get advisory credit as well. Often what happens on larger buy-side transactions is that a lot of BBs are brought on for financing and all get advisory credit while a single BB or EB does most of the actual advisory.
del
Anybody got any tech league tables by any chance?
Not perfect since Industrials is a collection of industries but here's the 2021 Industrials league tables.
Global
United States
Deutsche is not a BB anymore lol
HC Table would be really clutch
Consumer league table?
EBs typically can shift quite a bit from year to year anywhere from ~10th to 30th in league tables depending on if they can land a few landmark deals that shoot them way up in league tables (ex. in 2019 Moelis was 14th in league tables with the Celgene/Bristol Myers Squibb adding $93B to their deal volume and PWP was 29th while it was basically flipped this year with PWP landing the $59B Warner Media/Discovery deal). Also, Moelis has a lot more transactions with undisclosed values compared to other EBs as they do far more sponsor deals than most other EBs, and league tables obviously don't take that into account.
Also, for what it's worth, most of the EBs have similar reputations to clients and across the street, and the difference in reputations comes from the junior level in terms of PE exits, which Moelis historically does very well in as their analysts get a super rigorous experience (generalist M&A/RX model, very lean + high deal volume = analysts get their reps in, firm and MDs have great relationships with sponsors which also helps out placement).
JEF has basically been continuing its trend, which is a good thing considering it's been the fastest growing bank on Wall Street for some time. JEF has been able to capitalize on building sponsor relationships through its LevFin practice over the past few years. Now that the sponsors that JEF helped finance are selling their Portcos, JEF is able to get a piece of that sell-side advisory. JEF has also been building its LevFin practice through its partnerships with Mass Mutual and SMBC.
JEF has also been very focused on poaching MDs (something like a fifth of MDs at JEF have been there for less than a year) across all industries, and they're a much stronger bank all-around compared to just a few years ago. They've also been focusing on expanding their HC practice through building relationships through their ECM practice (HC ECM 2021 League Tables shown below).
That being said, JEF also has some growing pains. I don't work at JEF, but I've heard some things from people I know at JEF that through their aggressive poaching strategy, they've picked up some a lot of great MDs but also quite some dead weight with very expensive guaranteed comp packages.
Just as a disclaimer reading these:
The dataset is only getting pulled off publicly announced transactions. As a result, any player that does deals sub $2B likely is getting undercounted massively because the deals might not get disclosed. Would guess BB’s like Goldman that have a strong mm presence and obviously mm players or EB’s that dabble in the UMM space aren’t being accurately represented. Fun to look at though.
Anyone got some older league tables by any chance? Would be interesting to see how everything has changed over time.
2018
2015
2011
2008
Dang RBC has been "almost a BB" for a decade.
Anyone got league tables for RE